US 2013/0172391 A1Published application

Pharmaceutical compositions

AssigneeAres Trading S.A.

InventorBJOERN C. KAHRS

Life of this patent

Estimating the term…

Abstract

The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.

Claims7

Dependent claims

A pharmaceutical composition comprising a glitazone and a fumaric acid monoalkyl ester and/or fumaric acid dialkyl ester and, optionally, one or more excipients.

Dependencies are inferred from the claim text.

Facts

Application: 13/756,687Filed 1 Feb 2013
Priority: EP 11194292.619 Dec 2011
Published: 4 Jul 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification33 codes

A61K 31/4439
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 31/12
Medicinal preparations containing organic active ingredients: ketones
A61K 31/16
Medicinal preparations containing organic active ingredients: amides, e.g. hydroxamic acids

Family

Application61/663,761Us provisional application · filed 25 Jun 2012
Application13/654,632Division · filed 18 Oct 2012
Application13/756,687Division
US 2013/0158077 A1Published application
US 2013/0172391 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results